Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Buildings: 2009-2010

  • Gyre Therapeutics' Buildings rose 3.71% to $1.2 million in Q4 2010 from the same period last year, while for Dec 2010 it was $1.2 million, marking a year-over-year increase of 3.71%. This contributed to the annual value of $1.2 million for FY2010, which is 3.71% up from last year.
  • Gyre Therapeutics' Buildings amounted to $1.2 million in Q4 2010, which was up 3.71% from $1.1 million recorded in Q4 2009.
  • In the past 5 years, Gyre Therapeutics' Buildings ranged from a high of $1.2 million in Q4 2010 and a low of $1.1 million during Q4 2009.
  • For the 2-year period, Gyre Therapeutics' Buildings averaged around $1.2 million, with its median value being $1.2 million (2009).
  • Data for Gyre Therapeutics' Buildings shows a peak YoY climbed of 3.71% (in 2010) over the last 5 years.
  • Gyre Therapeutics' Buildings (Quarterly) stood at $1.1 million in 2009, then rose by 3.71% to $1.2 million in 2010.